Cargando…

Improved labelling of DTPA- and DOTA-conjugated peptides and antibodies with (111)In in HEPES and MES buffer

BACKGROUND: In single photon emission computed tomography [SPECT], high specific activity of (111)In-labelled tracers will allow administration of low amounts of tracer to prevent receptor saturation and/or side effects. To increase the specific activity, we studied the effect of the buffer used dur...

Descripción completa

Detalles Bibliográficos
Autores principales: Brom, Maarten, Joosten, Lieke, Oyen, Wim JG, Gotthardt, Martin, Boerman, Otto C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292493/
https://www.ncbi.nlm.nih.gov/pubmed/22284727
http://dx.doi.org/10.1186/2191-219X-2-4
_version_ 1782225283891331072
author Brom, Maarten
Joosten, Lieke
Oyen, Wim JG
Gotthardt, Martin
Boerman, Otto C
author_facet Brom, Maarten
Joosten, Lieke
Oyen, Wim JG
Gotthardt, Martin
Boerman, Otto C
author_sort Brom, Maarten
collection PubMed
description BACKGROUND: In single photon emission computed tomography [SPECT], high specific activity of (111)In-labelled tracers will allow administration of low amounts of tracer to prevent receptor saturation and/or side effects. To increase the specific activity, we studied the effect of the buffer used during the labelling procedure: NaAc, NH(4)Ac, HEPES and MES buffer. The effect of the ageing of the (111)InCl(3 )stock and cadmium contamination, the decay product of (111)In, was also examined in these buffers. METHODS: Escalating amounts of (111)InCl(3 )were added to 1 μg of the diethylene triamine pentaacetic acid [DTPA]- and 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid [DOTA]-conjugated compounds (exendin-3, octreotide and anti-carbonic anhydrase IX [CAIX] antibody). Five volumes of 2-(N-morpholino)ethanesulfonic acid [MES], 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid [HEPES], NH(4)Ac or NaAc (0.1 M, pH 5.5) were added. After 20 min at 20°C (DTPA-conjugated compounds), at 95°C (DOTA-exendin-3 and DOTA-octreotide) or at 45°C (DOTA-anti-CAIX antibody), the labelling efficiency was determined by instant thin layer chromatography. The effect of the ageing of the (111)InCl(3 )stock on the labelling efficiency of DTPA-exendin-3 as well as the effect of increasing concentrations of Cd(2+ )(the decay product of (111)In) were also examined. RESULTS: Specific activities obtained for DTPA-octreotide and DOTA-anti-CAIX antibody were five times higher in MES and HEPES buffer. Radiolabelling of DTPA-exendin-3, DOTA-exendin-3 and DTPA-anti-CAIX antibody in MES and HEPES buffer resulted in twofold higher specific activities than that in NaAc and NH(4)Ac. Labelling of DTPA-exendin-3 decreased with 66% and 73% for NaAc and NH(4)Ac, respectively, at day 11 after the production date of (111)InCl(3), while for MES and HEPES, the maximal decrease in the specific activity was 10% and 4% at day 11, respectively. The presence of 1 pM Cd(2+ )in the labelling mixture of DTPA-exendin-3 in NaAc and NH(4)Ac markedly reduced the labelling efficiency, whereas Cd(2+ )concentrations up to 0.1 nM did not affect the labelling efficiency in MES and HEPES buffer. CONCLUSIONS: We showed improved labelling of DTPA- and DOTA-conjugated compounds with (111)In in HEPES and MES buffer. The enhanced labelling efficiency appears to be due to the reduced competitive chelation of cadmium. The enhanced labelling efficiency will allow more sensitive imaging of the biomarkers with SPECT.
format Online
Article
Text
id pubmed-3292493
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Springer
record_format MEDLINE/PubMed
spelling pubmed-32924932012-03-06 Improved labelling of DTPA- and DOTA-conjugated peptides and antibodies with (111)In in HEPES and MES buffer Brom, Maarten Joosten, Lieke Oyen, Wim JG Gotthardt, Martin Boerman, Otto C EJNMMI Res Original Research BACKGROUND: In single photon emission computed tomography [SPECT], high specific activity of (111)In-labelled tracers will allow administration of low amounts of tracer to prevent receptor saturation and/or side effects. To increase the specific activity, we studied the effect of the buffer used during the labelling procedure: NaAc, NH(4)Ac, HEPES and MES buffer. The effect of the ageing of the (111)InCl(3 )stock and cadmium contamination, the decay product of (111)In, was also examined in these buffers. METHODS: Escalating amounts of (111)InCl(3 )were added to 1 μg of the diethylene triamine pentaacetic acid [DTPA]- and 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid [DOTA]-conjugated compounds (exendin-3, octreotide and anti-carbonic anhydrase IX [CAIX] antibody). Five volumes of 2-(N-morpholino)ethanesulfonic acid [MES], 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid [HEPES], NH(4)Ac or NaAc (0.1 M, pH 5.5) were added. After 20 min at 20°C (DTPA-conjugated compounds), at 95°C (DOTA-exendin-3 and DOTA-octreotide) or at 45°C (DOTA-anti-CAIX antibody), the labelling efficiency was determined by instant thin layer chromatography. The effect of the ageing of the (111)InCl(3 )stock on the labelling efficiency of DTPA-exendin-3 as well as the effect of increasing concentrations of Cd(2+ )(the decay product of (111)In) were also examined. RESULTS: Specific activities obtained for DTPA-octreotide and DOTA-anti-CAIX antibody were five times higher in MES and HEPES buffer. Radiolabelling of DTPA-exendin-3, DOTA-exendin-3 and DTPA-anti-CAIX antibody in MES and HEPES buffer resulted in twofold higher specific activities than that in NaAc and NH(4)Ac. Labelling of DTPA-exendin-3 decreased with 66% and 73% for NaAc and NH(4)Ac, respectively, at day 11 after the production date of (111)InCl(3), while for MES and HEPES, the maximal decrease in the specific activity was 10% and 4% at day 11, respectively. The presence of 1 pM Cd(2+ )in the labelling mixture of DTPA-exendin-3 in NaAc and NH(4)Ac markedly reduced the labelling efficiency, whereas Cd(2+ )concentrations up to 0.1 nM did not affect the labelling efficiency in MES and HEPES buffer. CONCLUSIONS: We showed improved labelling of DTPA- and DOTA-conjugated compounds with (111)In in HEPES and MES buffer. The enhanced labelling efficiency appears to be due to the reduced competitive chelation of cadmium. The enhanced labelling efficiency will allow more sensitive imaging of the biomarkers with SPECT. Springer 2012-01-27 /pmc/articles/PMC3292493/ /pubmed/22284727 http://dx.doi.org/10.1186/2191-219X-2-4 Text en Copyright ©2012 Brom et al; licensee Springer. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Brom, Maarten
Joosten, Lieke
Oyen, Wim JG
Gotthardt, Martin
Boerman, Otto C
Improved labelling of DTPA- and DOTA-conjugated peptides and antibodies with (111)In in HEPES and MES buffer
title Improved labelling of DTPA- and DOTA-conjugated peptides and antibodies with (111)In in HEPES and MES buffer
title_full Improved labelling of DTPA- and DOTA-conjugated peptides and antibodies with (111)In in HEPES and MES buffer
title_fullStr Improved labelling of DTPA- and DOTA-conjugated peptides and antibodies with (111)In in HEPES and MES buffer
title_full_unstemmed Improved labelling of DTPA- and DOTA-conjugated peptides and antibodies with (111)In in HEPES and MES buffer
title_short Improved labelling of DTPA- and DOTA-conjugated peptides and antibodies with (111)In in HEPES and MES buffer
title_sort improved labelling of dtpa- and dota-conjugated peptides and antibodies with (111)in in hepes and mes buffer
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292493/
https://www.ncbi.nlm.nih.gov/pubmed/22284727
http://dx.doi.org/10.1186/2191-219X-2-4
work_keys_str_mv AT brommaarten improvedlabellingofdtpaanddotaconjugatedpeptidesandantibodieswith111ininhepesandmesbuffer
AT joostenlieke improvedlabellingofdtpaanddotaconjugatedpeptidesandantibodieswith111ininhepesandmesbuffer
AT oyenwimjg improvedlabellingofdtpaanddotaconjugatedpeptidesandantibodieswith111ininhepesandmesbuffer
AT gotthardtmartin improvedlabellingofdtpaanddotaconjugatedpeptidesandantibodieswith111ininhepesandmesbuffer
AT boermanottoc improvedlabellingofdtpaanddotaconjugatedpeptidesandantibodieswith111ininhepesandmesbuffer